New method maps DNA changes in thousands of single cells
A new technique called scEM-seq allows scientists to study how DNA methylation regulates gene expression and disease.
Researchers developed scEM-seq, a droplet-based single-cell enzymatic methylome sequencing method. This tool profiles tens of thousands of single cells per experiment.
The method uses barcode ligation within a single emulsification step. This is followed by postemulsion cytosine-to-uracil conversion. DNA methylation is an epigenetic modification that regulates gene expression and cellular identity.
Previous high-throughput single-cell DNA methylation technologies faced several limits. These included DNA degradation, low CpG recovery, and poor scalability of bisulfite-based methods.
scEM-seq generates high-quality single-cell methylomes. It provides moderately improved CpG coverage and balanced read utilization compared to other droplet-based microfluidic methods.
The method accurately resolves major immune lineages in peripheral blood mononuclear cells. In prostate cancer tissues, it reveals diverse malignant cell states and patient-specific epigenetic and copy number architectures.
This technique enables scalable single-cell dissection of epigenetic heterogeneity. It broadens the scope of DNA methylation-based studies into cellular regulation and disease.
Key facts
- scEM-seq can profile tens of thousands of single cells in one experiment.
- The method reduces DNA loss compared to previous technologies.
- The tool reveals diverse malignant cell states in prostate cancer tissues.